Subscribe to RSS
DOI: 10.1055/s-0031-1290606
Synthesis of 1-Indol-3-yl-carbazoles via Garratt-Braverman Cyclization
Publication History
Publication Date:
15 March 2012 (online)
![](https://www.thieme-connect.de/media/synlett/201206/lookinside/thumbnails/10.1055-s-0031-1290606-1.jpg)
Abstract
Various indolyl carbazoles have been prepared in good yields utilizing Garratt-Braverman cyclization of bisindolyl propargyl sulfones, ethers, and amines as the key step.
Key word
Garratt-Braverman cyclization - carbazole - indole - alkaloid - Sonogashira coupling - sulfone
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Knölker H.-J.Reddy KR. Chem. Rev. 2002, 102: 4303 -
1b
Chakraborty DP. In The Alkaloids Vol. 44:Cordell GA. Academic Press; New York: 1993. p.257 ; and references cited therein -
1c
Knölker H.-J. Curr. Org. Synth. 2004, 1: 309 -
1d
Knölker H.-J. Top. Curr. Chem. 2005, 244: 115 -
1e
Knölker HJ.Reddy KR. In The Alkaloids Vol. 65:Cordell GA. Academic Press; Amsterdam: 2008. p.1 -
1f
Jana AK.Mal D. Chem. Commun. 2010, 46: 4411 - 2
Irlinger B.Bartsch A.Kramer H.-J.Mayser P.Steglich W. Helv. Chim. Acta 2005, 88: 1472 - 3
Gupta AK.Bluhm R.Summerbell R. J. Eur. Acad. Dermatol. Venereol. 2002, 16: 19 - 4
Forke R.Jager A.Knölker H.-J. Org. Biomol. Chem. 2008, 6: 2481 -
5a
Agenet N.Buisine O.Slowinski F.Gandon V.Aubert C.Malacria M. Org. React. 2007, 68: 1 -
5b
Vollhardt KPC. Angew. Chem., Int. Ed. Engl. 1984, 23: 539 - 6
Dötz KH. Angew. Chem., Int. Ed. Engl. 1975, 14: 644 -
7a
Jones RG.Bergman RG. J. Am. Chem. Soc. 1972, 94: 660 -
7b
Bergman RG. Acc. Chem. Res. 1973, 6: 25 -
7c
Lockhart TP.Bergman RG. J. Am. Chem. Soc. 1981, 103: 4091 -
7d
Nicolaou KC.Zuccarello G.Oogawa Y.Schweiger EJ.Kumazawa T. J. Am. Chem. Soc. 1988, 110: 4866 - 8
Cycloaddition
Reactions in Organic Synthesis
Kobayashi S.Jorgensen KA. Wiley-VCH; New York: 2002. -
9a
Nagata R.Yamanaka H.Okazaki E.Saito I. Tetrahedron Lett. 1989, 30: 4995 -
9b
Myers AG.Kuo EY.Finney NS. J. Am. Chem. Soc. 1989, 111: 8057 -
9c
Myers AG.Dragovich PS. J. Am. Chem. Soc. 1989, 111: 9130 -
9d
Nagata R.Yamanaka H.Murahashi E.Saito I. Tetrahedron Lett. 1990, 31: 2907 -
10a
Braverman S.Segev D. J. Am. Chem. Soc. 1974, 96: 1245 -
10b
Garratt PJ.Neoh SB. J. Org. Chem. 1979, 44: 2667 -
10c
Cheng YSP.Garratt PJ.Neoh SB.Rumjanek VH. Isr. J. Chem. 1985, 26: 101 -
10d
Braverman S.Duar Y.Segev D. Tetrahedron Lett. 1976, 17: 3181 -
10e
Zafrani Y.Gottlieb HE.Sprecher M.Braverman S. J. Org. Chem. 2005, 70: 10166 -
11a
Maji M.Mallick D.Mondal S.Anoop A.Bag SS.Basak A.Jemmis ED. Org. Lett. 2011, 13: 888 -
11b
Mondal S.Maji M.Basak A. Tetrahedron Lett. 2011, 52: 1183 -
11c
Addy PS.Dutta S.Biradha K.Basak A. Tetrahedron Lett. 2012, 53: 19 -
13a
Sonogashira K.Tohda Y.Hagihara N. Tetrahedron Lett. 1975, 16: 4467 -
13b
Takahashi K.Kuroyama Y.Sonogashira K.Hagihara N. Synthesis 1980, 627
References and Notes
The indole nitrogen had to be protected due to the instability of 3-iodoindole under Pd(0)-catalyzed reaction conditions.
14CCDC 848846 contains the crystallographic data for this paper.
15All compounds were characterized by
NMR and MS analysis.
Spectral Data
of Selected Compounds
Compound 18a: ¹H
NMR (400 MHz, CDCl3): δ = 8.30 (d, J = 8.0 Hz,
1 H), 8.08 (d, J = 8.4
Hz, 1 H), 8.03 (s, 1 H), 8.01 (s, 1 H), 7.64 (s, 1 H), 7.55-7.51
(m, 1 H), 7.44-7.41 (m, 1 H), 7.28-7.27 (2 H,
m), 4.62 (s, 2 H), 4.57-4.52 (m, 2 H), 4.45, 4.31 (ABq, J = 16.0 Hz,
2 H), 3.75-3.69 (m, 1 H), 3.30-3.25 (m, 1 H),
1.49 (t, J = 5.2
Hz, 3 H), 0.75 (t, J = 7.2 Hz,
3 H). ¹³C NMR (100 MHz, CDCl
3): δ = 151.2,
150.6, 139.9, 137.5, 135.2, 130.6, 128.6, 128.1, 128.0, 126.5, 125.4,
124.3, 123.6, 123.5, 122.7, 119.9, 119.8, 119.6, 118.9, 116.9, 115.5,
114.8, 63.6, 63.2, 57.5, 57.4, 14.3, 13.4. HRMS: m/z calcd
for C28H24N2O2S + H+:
517.1433; found: 517.1440.
Compound 21a: ¹H
NMR (400 MHz, CD3COCD3): δ = 10.7 (br
s, 1 H), 10.0 (br s, 1 H), 8.16 (s, 1 H), 8.14 (s, 1 H), 7.67-7.66
(m, 1 H), 7.57 (d, J = 8.0
Hz, 1 H), 7.49 (d, J = 8.4
Hz, 1 H), 7.37 (t, J = 7.6
Hz, 1 H), 7.30 (d, J = 8.0
Hz, 1 H), 7.23-7.18 (m, 2 H), 7.07 (t, J = 7.6
Hz, 1 H), 4.64 (s, 2 H), 4.39, 4.33 (ABq, J = 16.0
Hz, 2 H). ¹³C NMR (100 MHz, CD3COCD3): δ = 140.7,
139.3, 137.0, 129.0, 126.5, 126.2, 125.1, 123.3, 123.2, 123.1, 122.2,
120.4, 120.0, 119.5, 119.3, 116.8, 116.3, 112.1, 111.5, 110.2, 57.3,
56.7. HRMS: m/z calcd for C22H16N2O2S + H+:
373.1011; found: 373.1014.
Compound 18b: ¹H
NMR (400 MHz, CDCl3): δ = 8.00 (s,
1 H), 7.90-7,88 (m, 1 H), 7.62 (s, 1 H), 7.27-7.18
(m, 4 H), 7.09 (d, J = 6.4
Hz, 1 H), 4.64, 4.58 (ABq, J = 15.6
Hz, 2 H), 4.50, 4.47 (ABq, J = 6.8
Hz, 2 H), 4.31, 4.14 (ABq, J = 16.4 Hz,
2 H), 3.71-3.63 (m, 1 H), 2.99-2.91 (m, 1 H),
2.72 (s, 3 H), 2.45 (s, 3 H), 1.46 (t, J = 6.8
Hz, 3 H), 0.73 (t, J = 7.2
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3): δ = 153.6,
150.5, 138.7, 138.5, 134.7, 130.5, 130.4, 128.8, 126.5, 126.2, 126.0, 124.6,
124.1, 124.0, 123.1, 122.4, 117.8, 117.5, 117.0, 116.6, 116.0, 64.1,
63.7, 57.5, 56.9, 22.0, 19.2, 14.2, 12.9. HRMS: m/z calcd
for C30H28N2O6S + H+:
545.1746; found: 545.1749.
Compound 21b: ¹H
NMR (400 MHz, CD3COCD3): δ = 10.6 (br
s, 1 H), 9.89 (br s, 1 H), 8.12 (s, 1 H), 7.99 (d, J = 8.4
Hz, 1 H), 7.64-7.63 (m, 1 H), 7.23-7.10 (m, 3
H), 7.05-6.95 (m, 2 H), 4.65, 4.60 (ABq, J = 15.2
Hz, 2 H), 4.37, 4.24 (ABq, J = 15.6
Hz, 2 H), 2.61 (s, 3 H), 2.42 (s, 3 H). ¹³C
NMR (100 MHz, CD3COCD3): δ = 139.7,
139.3, 136.2, 128.8, 126.7, 126.2, 124.6, 123.6, 123.9, 122.6, 122.5,
121.1, 120.7, 120.0, 119.4, 117.7, 116.9, 116.0, 110.4, 57.1, 56.6,
16.3, 16.1. HRMS: m/z calcd
for C24H20N2O2S + H+:
401.1324; found: 401.1317.
Compound 11c: ¹H
NMR (400 MHz, CDCl3): δ = 7.99 (d, J = 8.8 Hz,
2 H), 7.78 (s, 2 H), 7.09 (d, J = 2.0
Hz, 2 H), 6.95 (dd, J = 2.0
Hz, 2 H), 4.50-4.43 (m, 8 H), 3.79 (s, 6 H), 1.45 (t, J = 7.2 Hz,
6 H). ¹³C NMR (100 MHz, CDCl3): δ = 156.9, 150.3,
131.3, 130.3, 129.2, 116.3, 114.9, 102.3, 102.2, 80.8, 80.1, 63.9,
55.8, 45.3, 14.5. HRMS: m/z calcd
for C30H28N2O8S + H+:
577.1645; found: 577.1649.
Compound 18c: ¹H
NMR (400 MHz, CDCl3): δ = 8.16 (d, J = 8.4 Hz,
1 H), 8.00 (d, J = 9.2
Hz, 1 H), 7.96 (s, 1 H), 7.60 (s, 1 H), 7.46 (dd, J = 2.4
Hz, 1 H), 7.11 (dd, J = 2.4
Hz, 1 H), 7.02 (dd, J = 2.4
Hz, 1 H), 6.69 (dd, J = 2.4
Hz, 1 H), 4.60 (s, 2 H), 4.54-4.49 (m, 2 H), 4.46, 4.33
(ABq, J = 16.4 Hz,
2 H), 3.94 (s, 3 H), 3.76-3.72 (m, 4 H), 3.40-3.36
(m, 1 H), 1.48 (t, J = 7.2
Hz, 3 H), 0.80 (t, J = 7.2
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3): δ = 156.8,
156.7, 151.5, 150.9, 138.2, 134.6, 130.9, 130.0, 129.7, 128.4, 126.7,
125.5, 123.5, 120.1, 119.1, 117.1, 116.6, 116.4, 116.2, 114.7, 103.2,
102.4, 63.8, 63.4, 57.7, 57.6, 56.1, 55.9, 14.6, 13.8. HRMS: m/z calcd for C30H28N2O8S + H+ 577.1645;
found: 577.1649.
Compound 21c: ¹H
NMR (400 MHz, CD3COCD3): δ = 10.6 (br
s, 1 H), 9.9 (br s, 1 H), 8.09 (s, 1 H), 7.35 (d, J = 2.0
Hz, 1 H), 7.61 (d, J = 1.6
Hz, 1 H), 7.44 (t, J = 9.2
Hz, 2 H), 7.03 (dd, J = 2.4
Hz, 1 H), 6.86 (dd, J = 2.4
Hz, 1 H), 6.77 (d, J = 2.0
Hz, 1 H), 4.60 (s, 2 H), 4.43, 4.34 (ABq, J = 15.6
Hz, 2 H), 3.88 (s, 3 H), 3.66 (s, 3 H). ¹³C
NMR (100 MHz, CD3COCD3): δ = 154.8,
154.2, 139.8, 135.5, 132.0, 128.7, 126.8, 125.5, 125.4, 123.5, 123.2,
122.6, 116.9, 116.2, 115.7, 112.9, 112.8, 112.2, 110.0, 102.9, 100.8,
57.2, 56.7, 55.4, 55.1. HRMS: m/z calcd
for C24H20N2O4S + H+: 433.1222;
found: 433.1227.